Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
Ministry of Health & Welfare. Korea health statistics 2014: Korea national health and nutrition examination survey (KNHANES IV-2). Seoul: Ministry of Health Welfare; 2015 Dec. 451 p.
Joo NS, Dawson-Hughes B, Yeum KJ. 25-Hydroxyvitamin D, calcium intake, and bone mineral content in adolescents and young adults: analysis of the fourth and fifth Korea national health and nutrition examination survey (KNHANES IV-2, 3, 2008-2009 and V-1, 2010). J Clin Endocrinol Metab 2013; 98: 3627-36.
Dessein PH. Vitamin D replacement therapy: a promising adjunct in cardiovascular risk management among patients with rheumatoid arthritis? J Rheumatol 2013; 40: 1463-5.
McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 2011; 155: 820-6.
McDermott MM, Liu K, Ferrucci L, Tian L, Guralnik J, Kopp P, et al. Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc Med 2014; 19: 18-26.
Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases. Am J Cardiol 2008; 102: 1540-4.
Melamed ML, Muntner P, Michos ED, Uribarri J, Weber C, Sharma J, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 1179-85.
van de Luijtgaarden KM, Voûte MT, Hoeks SE, Bakker EJ, Chonchol M, Stolker RJ, et al. Vitamin D deficiency may be an independent risk factor for arterial disease. Eur J Vasc Endovasc Surg 2012; 44: 301-6.
Reis JP, Michos ED, von Mühlen D, Miller ER 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008; 88: 1469-77.
Amer M, Narotsky DL, Qayyum R. 25-Hydroxyvitamin D and ankle-brachial blood pressure index in adults without peripheral artery disease. Clin Transl Sci 2014; 7: 391-5.
Veronese N, De Rui M, Bolzetta F, Toffanello ED, Coin A, Zambon S, et al. Serum 25-hydroxyvitamin D and the incidence of peripheral artery disease in the elderly. J Atheroscler Thromb 2015; 22: 726-34.
Nsengiyumva V, Fernando ME, Moxon JV, Krishna SM, Pinchbeck J, Omer SM, et al. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis 2015; 243: 645-51.
Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106: 963-8.
Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-56.
Wallis DE, Penckofer S, Sizemore GW. The “sunshine deficit” and cardiovascular disease. Circulation 2008; 118: 1476-85.
World Health Organization. Prevention and management of osteoporosis:report of a WHO scientific group. Report of a WHO Scientific Group, Geneva, 2000. WHO Technical report series 921. Geneva: World Health Organization;2003. p 92-3.
Oh SH, Kweon SS, Choi JS, Rhee JA, Lee YH, Nam HS, et al. Association between vitamin D status and risk of peripheral arterial disease: the Dong-gu study. Chonnam Med J 2016; 52: 212-6.
Rajasree S, Rajpal K, Kartha CC, Sarma PS, Kutty VR, Iyer CS, et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001; 17: 567-71.
Toda T, Toda Y, Kummerow FA. Coronary arterial lesions in piglets from sows fed moderate excesses of vitamin D. Tohoku J Exp Med 1985; 145:303-10.
Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007; 18: 41-6.
Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation 2013; 128: 2517-31.
Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R. 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000; 102: 2867-72.
Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515-22.
Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice. J Clin Endocrinol Metab 2012; 97:2644-52.